{
"NDC": {
"NDCCode": "37808-614-05",
"PackageDescription": "355 mL in 1 BOTTLE (37808-614-05) ",
"NDC11Code": "37808-0614-05",
"ProductNDC": "37808-614",
"ProductTypeName": "HUMAN OTC DRUG",
"ProprietaryName": "Supreme Antacid",
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Calcium Carbonate, Magnesium Hydroxide",
"DosageFormName": "LIQUID",
"RouteName": "ORAL",
"StartMarketingDate": "20250207",
"EndMarketingDate": null,
"MarketingCategoryName": "OTC MONOGRAPH DRUG",
"ApplicationNumber": "M001",
"LabelerName": "H E B",
"SubstanceName": "CALCIUM CARBONATE; MAGNESIUM HYDROXIDE",
"StrengthNumber": "800; 270",
"StrengthUnit": "mg/10mL; mg/10mL",
"Pharm_Classes": "Blood Coagulation Factor [EPC], Calcium [CS], Calculi Dissolution Agent [EPC], Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]",
"DEASchedule": null,
"Status": "Active",
"LastUpdate": "2025-03-17",
"PackageNdcExcludeFlag": "N",
"ProductNdcExcludeFlag": "N",
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "20250207",
"EndMarketingDatePackage": null,
"SamplePackage": "N"
}
}